Cargando…
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
While the world is facing the urgency of the COVID-19 pandemic, policymakers must plan for the direct response to the outbreak while minimising its collateral impact. Maintaining the supply chain of pharmaceutical products is not only paramount to cover the immediate medical response but will be fun...
Autores principales: | Guerin, Philippe J, Singh-Phulgenda, Sauman, Strub-Wourgaft, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284150/ https://www.ncbi.nlm.nih.gov/pubmed/32566139 http://dx.doi.org/10.12688/f1000research.23057.1 |
Ejemplares similares
-
Gender disparity in cases enrolled in clinical trials of visceral leishmaniasis: A systematic review and meta-analysis
por: Dahal, Prabin, et al.
Publicado: (2021) -
Guidelines should not pool evidence from uncomplicated and severe COVID-19
por: White, Nicholas J, et al.
Publicado: (2021) -
WHO COVID-19 therapeutic guidelines – Authors' reply
por: White, Nicholas J, et al.
Publicado: (2021) -
The Boom in Nanomaterials for Built Heritage Conservation: Why Does Size Matter?
por: Otero, Jorge, et al.
Publicado: (2023) -
Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans
por: Dahal, Prabin, et al.
Publicado: (2021)